Detalles de la búsqueda
1.
Modulations of the amide function of the preferential dopamine D3 agonist (R,R)-S32504: improvements of affinity and selectivity for D3 versus D2 receptors.
Bioorg Med Chem Lett
; 19(8): 2133-8, 2009 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19324548
2.
Synthesis of benzocyclobutenes by palladium-catalyzed C-H activation of methyl groups: method and mechanistic study.
J Am Chem Soc
; 130(45): 15157-66, 2008 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18928284
3.
Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
Psychopharmacology (Berl)
; 191(3): 767-82, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17047933
4.
Characterization of the Annonaceous acetogenin, annonacinone, a natural product inhibitor of plasminogen activator inhibitor-1.
Sci Rep
; 6: 36462, 2016 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27876785
5.
Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
J Med Chem
; 45(1): 165-76, 2002 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-11754589
6.
In vivo quantification of myocardial dihydropyridine binding sites: a PET study in dogs.
J Nucl Med
; 43(9): 1227-33, 2002 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12215563
7.
Differential influence of selective 5-HT5A vs 5-HT1A, 5-HT1B, or 5-HT2C receptor blockade upon light-induced phase shifts in circadian activity rhythms: interaction studies with citalopram.
Eur Neuropsychopharmacol
; 19(12): 887-97, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19604677
8.
Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs.
J Cardiovasc Pharmacol
; 42(5): 688-96, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14576519
9.
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
J Pharmacol Exp Ther
; 309(3): 903-20, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-14978194
10.
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole.
J Pharmacol Exp Ther
; 309(3): 936-50, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-14978196
11.
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis.
J Pharmacol Exp Ther
; 311(1): 190-203, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15146031
12.
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: II. Actions in rodent, primate, and cellular models of antiparkinsonian activity in comparison to ropinirole.
J Pharmacol Exp Ther
; 309(3): 921-35, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-14978195
Resultados
1 -
12
de 12
1
Próxima >
>>